Baseline Eosinophil Levels and FeNO as Predictors of Exacerbations in Asthma and COPD
-
By
-
Debbie Bunch
-
June 15, 2026
By
Debbie Bunch
June 15, 2026
Phase 3 SUNRISE trial evaluates whether patients with severe asthma can taper maintenance oral corticosteroids while maintaining asthma control.
June 25, 2026